Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.300
0.00 (0.00%)
May 5, 2026, 4:00 PM EDT - Market closed
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$839,840
Market Cap
5.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | 1 | 12.50% |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Mar 31, 2021 | 7 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| BiomX | 20 |
| Cardio Diagnostics Holdings | 17 |
| BioRestorative Therapies | 14 |
| Akari Therapeutics, | 6 |
| Indaptus Therapeutics | 5 |
| Mustang Bio | 4 |
DRMA News
- 4 weeks ago - Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - Accesswire
- 5 weeks ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Accesswire
- 6 weeks ago - Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance - Benzinga
- 2 months ago - Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Accesswire
- 2 months ago - Dermata Opens a New Chapter with the Release of Tome Skincare - Accesswire
- 3 months ago - Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office - Accesswire
- 4 months ago - Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire
- 4 months ago - Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire